Novel pathways for negative regulation of inflammatory cytokines

Research output: Contribution to journalArticle

Abstract

Inflammatory cytokines act in cascades. Pro and anti-inflammatory signals regulate the production of primary and secondary inflammatory cytokines. A number of studies have investigated the actual role played by the two receptors, RI and RII, in interleukin (IL)-1 signaling. All available evidences, including tissue distribution and monoclonal antibodies blocking studies, indicate that IL-1-induced activities are mediated exclusively via the IL-1RI, whereas IL-1RII has no signaling activity and inhibits IL-1 effects by acting as a decoy for IL-1, thus sequestering it and preventing the cytokine from binding to the IL-1RI, IL-1RII may represent a physiological pathway of inhibition of IL-1. Induction of expression and release of the IL-1RII may contribute to the antiinflammatory properties of Th2-derived cytokines and glucocorticoids. Other studies on chemokine receptors show that lipopolysaccharides cause a drastic and rapid downregulation of the expression of CCR2, a receptor for macrophage chemotactic proteins (MCP)-1 and -3.

Original languageEnglish
Pages (from-to)137-140
Number of pages4
JournalBiotecnologia Aplicada
Volume15
Issue number3
Publication statusPublished - 1998

Fingerprint

Interleukins
Interleukin-1
Cytokines
Anti-Inflammatory Agents
CCR2 Receptors
Chemokine Receptors
Tissue Distribution
Glucocorticoids
Lipopolysaccharides
Down-Regulation
Macrophages
Monoclonal Antibodies
Proteins

Keywords

  • Chemokines
  • Inflammation
  • Interleukin-1
  • Receptors

ASJC Scopus subject areas

  • Biotechnology
  • Applied Microbiology and Biotechnology

Cite this

Novel pathways for negative regulation of inflammatory cytokines. / Mantovani, A.

In: Biotecnologia Aplicada, Vol. 15, No. 3, 1998, p. 137-140.

Research output: Contribution to journalArticle

@article{f668a43a1e844402ac77d318f420106b,
title = "Novel pathways for negative regulation of inflammatory cytokines",
abstract = "Inflammatory cytokines act in cascades. Pro and anti-inflammatory signals regulate the production of primary and secondary inflammatory cytokines. A number of studies have investigated the actual role played by the two receptors, RI and RII, in interleukin (IL)-1 signaling. All available evidences, including tissue distribution and monoclonal antibodies blocking studies, indicate that IL-1-induced activities are mediated exclusively via the IL-1RI, whereas IL-1RII has no signaling activity and inhibits IL-1 effects by acting as a decoy for IL-1, thus sequestering it and preventing the cytokine from binding to the IL-1RI, IL-1RII may represent a physiological pathway of inhibition of IL-1. Induction of expression and release of the IL-1RII may contribute to the antiinflammatory properties of Th2-derived cytokines and glucocorticoids. Other studies on chemokine receptors show that lipopolysaccharides cause a drastic and rapid downregulation of the expression of CCR2, a receptor for macrophage chemotactic proteins (MCP)-1 and -3.",
keywords = "Chemokines, Inflammation, Interleukin-1, Receptors",
author = "A. Mantovani",
year = "1998",
language = "English",
volume = "15",
pages = "137--140",
journal = "Biotecnologia Aplicada",
issn = "0864-4551",
publisher = "Elfos Scientiae",
number = "3",

}

TY - JOUR

T1 - Novel pathways for negative regulation of inflammatory cytokines

AU - Mantovani, A.

PY - 1998

Y1 - 1998

N2 - Inflammatory cytokines act in cascades. Pro and anti-inflammatory signals regulate the production of primary and secondary inflammatory cytokines. A number of studies have investigated the actual role played by the two receptors, RI and RII, in interleukin (IL)-1 signaling. All available evidences, including tissue distribution and monoclonal antibodies blocking studies, indicate that IL-1-induced activities are mediated exclusively via the IL-1RI, whereas IL-1RII has no signaling activity and inhibits IL-1 effects by acting as a decoy for IL-1, thus sequestering it and preventing the cytokine from binding to the IL-1RI, IL-1RII may represent a physiological pathway of inhibition of IL-1. Induction of expression and release of the IL-1RII may contribute to the antiinflammatory properties of Th2-derived cytokines and glucocorticoids. Other studies on chemokine receptors show that lipopolysaccharides cause a drastic and rapid downregulation of the expression of CCR2, a receptor for macrophage chemotactic proteins (MCP)-1 and -3.

AB - Inflammatory cytokines act in cascades. Pro and anti-inflammatory signals regulate the production of primary and secondary inflammatory cytokines. A number of studies have investigated the actual role played by the two receptors, RI and RII, in interleukin (IL)-1 signaling. All available evidences, including tissue distribution and monoclonal antibodies blocking studies, indicate that IL-1-induced activities are mediated exclusively via the IL-1RI, whereas IL-1RII has no signaling activity and inhibits IL-1 effects by acting as a decoy for IL-1, thus sequestering it and preventing the cytokine from binding to the IL-1RI, IL-1RII may represent a physiological pathway of inhibition of IL-1. Induction of expression and release of the IL-1RII may contribute to the antiinflammatory properties of Th2-derived cytokines and glucocorticoids. Other studies on chemokine receptors show that lipopolysaccharides cause a drastic and rapid downregulation of the expression of CCR2, a receptor for macrophage chemotactic proteins (MCP)-1 and -3.

KW - Chemokines

KW - Inflammation

KW - Interleukin-1

KW - Receptors

UR - http://www.scopus.com/inward/record.url?scp=0031724862&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031724862&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0031724862

VL - 15

SP - 137

EP - 140

JO - Biotecnologia Aplicada

JF - Biotecnologia Aplicada

SN - 0864-4551

IS - 3

ER -